We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Revolutionary Transistor Could Allow Wearable Devices to Measure Sodium and Potassium in Blood

By LabMedica International staff writers
Posted on 23 Jan 2023
Print article
Image: The vertical electrochemical transistor is based on a new kind of electronic polymer and a vertical, instead of planar architecture (Photo courtesy of Northwestern University)
Image: The vertical electrochemical transistor is based on a new kind of electronic polymer and a vertical, instead of planar architecture (Photo courtesy of Northwestern University)

Researchers have developed a revolutionary transistor that could be suitable for lightweight, flexible, high-performance bioelectronics. The electrochemical transistor is compatible with blood and water and can amplify important signals, paving the way for its application in biomedical sensing. The transistor could allow for the use of wearable devices for onsite signal processing, right at the biology-device interface. Some of its likely applications could be for measuring heartbeat and the levels of sodium and potassium in blood, as well as eye motion in studies of sleep disorders.

The vertical electrochemical transistor developed by a transdisciplinary research team at Northwestern University (Evanston, IL, USA) is based on a new kind of electronic polymer and a vertical, instead of planar, architecture. The transistor conducts electricity as well as ions, and is stable in air. The design and synthesis of the new materials, and the fabrication and characterization of the transistor was made possible by the collaborative expertise of chemists, materials scientists and biomedical engineers in the research team.

In order to make electronic circuits more reliable and powerful, there is a need for two types of transistors: p-type transistors that carry positive charges and n-type transistors that carry negative charges. These types of circuits are called complementary circuits. In the past, researchers have faced a challenge in building n-type transistors which are also typically unstable. The work by the transdisciplinary research team is the first to demonstrate electrochemical transistors with similar and very high performance for both types (p+n) of electrochemical transistors. This helped the researchers fabricate highly efficient electrochemical complementary circuits.

“All modern electronics use transistors, which rapidly turn current on and off,” said Tobin J. Marks, a co-corresponding author of the study. “Here we use chemistry to enhance the switching. Our electrochemical transistor takes performance to a totally new level. You have all the properties of a conventional transistor but far higher transconductance (a measure of the amplification it can deliver), ultra-stable cycling of the switching properties, a small footprint that can enable high density integration, and easy, low-cost fabrication.”

“This exciting new type of transistor allows us to speak the language of both biological systems, which often communicate via ionic signaling, and electronic systems, which communicate with electrons,” said Jonathan Rivnay, professor of biomedical engineering at the McCormick School. “The ability of the transistors to work very efficiently as ‘mixed conductors’ makes them attractive for bioelectronic diagnostics and therapies.”

Related Links:
Northwestern University 

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.